Unprecedented Growth Opportunity - PowerPoint PPT Presentation

Loading...

PPT – Unprecedented Growth Opportunity PowerPoint presentation | free to download - id: 2f395-NTZjY



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Unprecedented Growth Opportunity

Description:

4th largest economy by PPP index. 6th largest energy consumer. ForEx reserves skyrocket from US$ 42 bn ... Hero Honda - largest manufacturer of motorcycles ... – PowerPoint PPT presentation

Number of Views:103
Avg rating:3.0/5.0
Slides: 31
Provided by: aparn
Learn more at: http://www.ibef.org
Category:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Unprecedented Growth Opportunity


1
Unprecedented Growth Opportunity
BIOTECHNOLOGY
2
Biotechnology
  • India - An Overview
  • Market and Growth Potential
  • Players
  • Opportunities
  • Why India?
  • Contact in India

3
India - An Introduction
Over 1 bn 35 3.3 mn sq kms 22 English US
534 US 650 bn
  • Population
  • States/UTs
  • Geographical Area
  • Languages recognised
  • Business language
  • Per Capita Income
  • GDP

(at factor cost at current prices) 1USD43.54
INR (as on July 4, 2005)
SourceCSO Statistics
4
India - Fast pace Growth
  • Largest democracy
  • 4th largest economy by PPP index
  • 6th largest energy consumer
  • ForEx reserves skyrocket from US 42 bn (2001)
    to
  • US 133 bn (February, 2005)
  • GDP growth to continue between 6-8
  • 3rd largest economy by 2050 Goldman Sachs
  • Leading in IT BPO
  • Oil Gas and Biotechnology sunrise industries

5
India - Leading the world
  • Hero Honda - largest manufacturer of motorcycles
  • Moser Baer - among the top three media
    manufacturers
  • in the world
  • Pharmaceutical Industry - 4th largest in world
  • Walmart, GAP, Hilfiger sources more than
  • USD 1bn worth apparel from India
  • 100 Fortune 500 have set RD facilities in India
  • including GE, Delphi, Eli Lilly, HP, Heinz
    and Daimler
  • Chrysler

6
Biotechnology
  • India - An Overview
  • Market and Growth Potential
  • Players
  • Opportunities
  • Why India?
  • Contact in India

7
Biotech Market - Dynamic and growing
  • Size (2004-05) US 1090.5 mn
  • Largest segment Biopharma
  • Revenue from exports (2003-04) 56
  • Total investment (2003-04) US 137
    million
  • Rate of growth over 202-2003 26

8
Biopharma leads the way
Composition of Indian Biotech Sector (2004-05)
Bio Industrial 6.74
SourceBiospectrum-ABLE Survey
9

Market - A consistent uptrend
25 growth in investment
2002-03
70 growth in employment
74 growth in RD manpower
US 5 billion annual revenues
2010
1 million skilled jobs
10 of global industry
Source Confederation of Indian Industry (CII)
10
Biotechnology
  • India - An Overview
  • Market and Growth Potential
  • Players
  • Opportunities
  • Why India?
  • Contact in India

11
Indian Players
12
MNCs Scripting Success in India
13
Biotechnology
  • India - An Overview
  • Market and Growth Potential
  • Players
  • Opportunities
  • Why India?
  • Contact in India

14
Investments
  • Annual investments in this sector will be of the
    order of US 150 mn and are growing at the rate
    of 25.
  • An additional investment of US 216 mn is
    expected in FY2005

15
Invest in Biopharmaceuticals
  • Vaccine Sales of US 383.6 mn (2004-05)
  • Therapeutic Marketing licenses granted for
  • over 25 recombinant therapeutic
  • proteins
  • Diagnostics Sales market - US 138.2 mn (2004-05)

16
India The Vaccine Hub
  • Indian firms estimated to supply 90 of global
    demand for the measles vaccine, in the near
    future.
  • Serum Institute, Pune is believed to be the
    worlds largest manufacturer of DPT vaccines.
  • Indian Immunologicals operates the worlds second
    largest plant for veterinary vaccines and is also
    the worlds largest manufacturer of the vaccine
    against Foot and Mouth Disease.

17
Invest in Biopharmaceuticals
  • Therapeutic Accounts for 16.7 of total
    biopharma
  • sales
  • Diagnostics Forecast to grow by 35-40 in
    2005
  • Immuno diagnostic market to increase
  • 4 to 5 folds by 2005

18
Invest in Bioinformatics
By 2006 bionformatics market to grow
2004-05 US 22.9 mn By 2006
US 120 mn
Source International Data Corporation (IDC)
  • Data mining
  • Gene annotation
  • Software bioinformatics
  • interface development

Opportunities for investment
19
Invest in Genomics and Industrial Biotech
  • Genomics
  • Industrial Biotech


  • Size (2004-05) US 73.5 mn

20
Invest in Agri Biotech
Biofertilisers
Biofuels
GM Crops and seeds
Biopesticides
21
Invest in Agri Biotech
Biofertilisers
Biofuels
GM Crops and seeds
Biopesticides
22
Clinical Trials - Destination India
Quality Speed Technology Disease
Profile Investigators Genetic diversity Ethics
  • Quality guidelines conformed
  • Patient enrolment rates upto six times higher
    than US
  • CROs to benefit from Indias IT
  • strengths in data management
  • High incidence of infectious/lifestyle diseases
  • Excellent pool of qualified trained doctors and
    physicians

23
Biotechnology
  • India - An Overview
  • Market and Growth Potential
  • Players
  • Opportunities
  • Why India?
  • Contact in India

24
The India Advantage
Excellent network of research laboratories
Well-developed base industries
Rich biodiversity
Extensive clinical trials opportunities
Trained manpower and knowledge base
25
The Infrastructure Advantage
  • 40 National Research
  • Institutes
  • 300 life sciences
  • colleges
  • 120 medical colleges
  • 200 biotech companies
  • 100 teaching hospitals

15,000 scientists 500,000 graduates per
annum 17,500 medical graduates per
annum Employing 25,000 scientists in
RD Employing medical paramedical
professionals
26
The R D Advantage
Genetic Engineering DNA technologies New Drug
Delivery Systems Rational drug design Stem cell
research Bioinformatics
Biotech RD strengths spread across range of
segments
27
The Policy Advantage
  • India has transitioned from a process patent
    regime to a product patent regime w.e.f January,
    2005
  • 150 weighted deduction on RD expenditure
  • Single window application processing proposed by
    DBT
  • New biotech proposals to be cleared within 150
    days
  • Formation of a SME Growth Fund to provide equity
    support to small medium units in the
    biotechnology sectors (Union Budget 2005-06)

28
Union Budget 2005-06
The Biotech Park Advantage
  • Benefits enjoyed by Export Oriented Units (EOU)
    extended to Biotech Parks
  • - 100 FDI permitted through automatic route
  • - BTP units exempt from payment of Income Tax
  • - Export proceeds to be realised within 12 months
  • - BTPs allowed to retain 100 export earnings in
    the EEFC account

29
Biotechnology
  • India - An Overview
  • Market and Growth Potential
  • Players
  • Opportunities
  • Why India?
  • Contact in India

30
Contact in India
Confederation of Indian Industry (CII) The
Mantosh Sodhi Centre 23 Institutional Area Lodi
Road New Delhi 110003 Tel 0091 11 24629994 -
7 Fax 0091 11 24626149/24615693 E-mail
c.banerjee_at_ciionline.org
About PowerShow.com